Contineum Therapeutics (CTNM) Institutional Ownership $13.65 +0.35 (+2.63%) (As of 11/20/2024 ET) Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrends Institutional Ownership Changes (13F Filings) for Contineum Therapeutics (NASDAQ:CTNM)Number ofInstitutional Buyers(last 12 months)12TotalInstitutional Inflows(last 12 months)$90.90MNumber ofInstitutional Sellers(last 12 months)3TotalInstitutional Outflows(last 12 months)$7.07M Get CTNM Insider Trade Alerts Want to know when executives and insiders are buying or selling Contineum Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data CTNM Institutional Buying and Selling by Quarter Ad DarwinNew Year, New Opportunity! 2 AI Stocks Under $10 Ready to SoarAs we step into 2025, artificial intelligence (AI) stocks continue to dominate headlines, and now is the perfect moment to position yourself for the coming year’s potential. Our latest research has uncovered two must-buy AI stocks currently trading under $10/share – an affordable entry with promising growth potential. These stocks are flying under the radar, but it’s only a matter of time before they gain mainstream attention.👉 Click here to access your FREE report now! Contineum Therapeutics Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails11/19/2024 Barclays PLC8,308$158K0.0%+248.6%0.032% 11/16/2024 Geode Capital Management LLC128,676$2.46M0.0%-17.7%0.500% 11/15/2024 Barclays PLC8,308$158K0.0%+248.6%0.032% 11/15/2024 State Street Corp113,566$2.17M0.0%+23.7%0.442% 11/14/2024 Suvretta Capital Management LLC1,720,000$32.92M1.1%-16.2%6.687% 11/13/2024 BNP Paribas Financial Markets6,743$129K0.0%+1,248.6%0.026% 11/13/2024 FMR LLC696,927$13.34M0.0%+115.4%2.710% 11/12/2024 Charles Schwab Investment Management Inc.43,295$829K0.0%-16.4%0.168% 8/16/2024 Perceptive Advisors LLC1,566,668$27.59M0.7%N/A6.091% 8/16/2024 Driehaus Capital Management LLC66,667$1.17M0.0%N/A0.259% 8/14/2024 Squarepoint Ops LLC150,000$2.64M0.0%N/A0.583% 8/14/2024 Sandia Investment Management LP5,000$88K0.1%N/A0.019% 8/9/2024 Johnson & Johnson1,979,173$34.85M8.7%N/A7.694% 8/8/2024 Versant Venture Management LLC918,163$16.17M20.9%N/A3.569% 8/1/2024 Rhumbline Advisers6,722$118K0.0%N/A0.026% 7/26/2024 Bank of New York Mellon Corp20,232$356K0.0%N/A0.079% (Data available from 1/1/2016 forward) CTNM Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of CTNM shares? During the previous two years, 15 institutional investors and hedge funds held shares of Contineum Therapeutics. The most heavily invested institutionals were Johnson & Johnson ($34.85M), Suvretta Capital Management LLC ($32.92M), Perceptive Advisors LLC ($27.59M), Versant Venture Management LLC ($16.17M), FMR LLC ($13.34M), Squarepoint Ops LLC ($2.64M), and Geode Capital Management LLC ($2.46M).Learn more on CTNM's institutional investors. Which institutional investors have been buying Contineum Therapeutics stock? Of the 12 institutional investors that purchased Contineum Therapeutics stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Johnson & Johnson ($1.98M), Perceptive Advisors LLC ($1.57M), Versant Venture Management LLC ($918.16K), FMR LLC ($373.33K), Squarepoint Ops LLC ($150K), Driehaus Capital Management LLC ($66.67K), and State Street Corp ($21.76K). How much institutional buying is happening at Contineum Therapeutics? Institutional investors have bought a total of 5,125,805 shares in the last 24 months. This purchase volume represents approximately $90.90M in transactions. Which Contineum Therapeutics major shareholders have been selling company stock? The following institutional investors have sold Contineum Therapeutics stock in the last 24 months: Suvretta Capital Management LLC ($333.33K), Geode Capital Management LLC ($27.75K), and Charles Schwab Investment Management Inc. ($8.48K). How much institutional selling is happening at Contineum Therapeutics? Institutional investors have sold a total of 369,556 shares in the last 24 months. This volume of shares sold represents approximately $7.07M in transactions. Related Companies DAWN Institutional Ownership TVTX Institutional Ownership PRAX Institutional Ownership SAVA Institutional Ownership SNDX Institutional Ownership SPRY Institutional Ownership RCUS Institutional Ownership KURA Institutional Ownership MESO Institutional Ownership GYRE Institutional Ownership This page (NASDAQ:CTNM) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Contineum Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Contineum Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free CTNM Stock Alerts